Dashboard
Manage Tickers

MGNXMACROGENICS INC

Nasdaq macrogenics.com


$ 3.44 $ 0.07 (2.07 %)    

Thursday, 08-Aug-2024 15:59:59 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 449.23 $ 13.30 (3.06 %)
DIA $ 395.05 $ 6.75 (1.74 %)
SPY $ 531.28 $ 11.99 (2.31 %)
TLT $ 95.30 $ -0.59 (-0.62 %)
GLD $ 224.00 $ 3.46 (1.57 %)
$ 3.45
$ 3.37
$ 3.44 x 200
$ 3.45 x 392
$ 3.28 - $ 3.53
$ 3.14 - $ 21.88
702,818
na
216.19M
$ 1.78
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-06-2024 06-30-2024 10-Q
2 05-09-2024 03-31-2024 10-Q
3 03-07-2024 12-31-2023 10-K
4 11-06-2023 09-30-2023 10-Q
5 08-09-2023 06-30-2023 10-Q
6 05-09-2023 03-31-2023 10-Q
7 03-15-2023 12-31-2022 10-K
8 11-03-2022 09-30-2022 10-Q
9 08-08-2022 06-30-2022 10-Q
10 05-03-2022 03-31-2022 10-Q
11 02-24-2022 12-31-2021 10-K
12 11-02-2021 09-30-2021 10-Q
13 07-29-2021 06-30-2021 10-Q
14 04-29-2021 03-31-2021 10-Q
15 02-25-2021 12-31-2020 10-K
16 11-04-2020 09-30-2020 10-Q
17 07-31-2020 06-30-2020 10-Q
18 05-05-2020 03-31-2020 10-Q
19 02-25-2020 12-31-2019 10-K
20 11-06-2019 09-30-2019 10-Q
21 07-31-2019 06-30-2019 10-Q
22 05-01-2019 03-31-2019 10-Q
23 02-26-2019 12-31-2018 10-K
24 11-07-2018 09-30-2018 10-Q
25 08-07-2018 06-30-2018 10-Q
26 05-07-2018 03-31-2018 10-Q
27 02-27-2018 12-31-2017 10-K
28 11-08-2017 09-30-2017 10-Q
29 08-02-2017 06-30-2017 10-Q
30 05-03-2017 03-31-2017 10-Q
31 02-28-2017 12-31-2016 10-K
32 11-02-2016 09-30-2016 10-Q
33 08-03-2016 06-30-2016 10-Q
34 05-04-2016 03-31-2016 10-Q
35 02-29-2016 12-31-2015 10-K
36 11-04-2015 09-30-2015 10-Q
37 08-05-2015 06-30-2015 10-Q
38 05-06-2015 03-31-2015 10-Q
39 03-03-2015 12-31-2014 10-K
40 11-12-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

bmo-capital-maintains-market-perform-on-macrogenics-lowers-price-target-to-5
BMO Capital Maintains Market Perform on Ma...
08/07/2024 15:12:31

BMO Capital analyst Etzer Darout maintains Macrogenics (NASDAQ:MGNX) with a Market Perform and lowers the price target from ...

macrogenics-q2-eps-089-misses-059-estimate-sales-1080m-miss-2124m-estimate
Macrogenics Q2 EPS $(0.89) Misses $(0.59) ...
08/06/2024 20:38:09

Macrogenics (NASDAQ:MGNX) reported quarterly losses of $(0.89) per share which missed the analyst consensus estimate of $(0.59)...

btig-downgrades-macrogenics-to-neutral
BTIG Downgrades Macrogenics to Neutral
08/01/2024 18:08:19

BTIG analyst Kaveri Pohlman downgrades Macrogenics (NASDAQ:MGNX) from Buy to Neutral.

hc-wainwright--co-reiterates-neutral-on-macrogenics-maintains-4-price-target
HC Wainwright & Co. Reiterates Neutral on ...
08/01/2024 10:17:55

HC Wainwright & Co. analyst Robert Burns reiterates Macrogenics (NASDAQ:MGNX) with a Neutral and maintains $4 price target.

jmp-securities-maintains-market-outperform-on-macrogenics-lowers-price-target-to-8
JMP Securities Maintains Market Outperform...
07/31/2024 18:16:44

JMP Securities analyst Silvan Tuerkcan maintains Macrogenics (NASDAQ:MGNX) with a Market Outperform and lowers the price tar...

after-reporting-five-patient-deaths-data-committee-recommends-macrogenics-halt-prostate-cancer-trial
After Reporting Five Patient Deaths, Data ...
07/31/2024 17:45:20

MacroGenics will discontinue vobra duo for remaining mCRPC participants after five deaths. New data to be presented at ESMO 202...

barclays-maintains-overweight-on-macrogenics-lowers-price-target-to-8
Barclays Maintains Overweight on Macrogeni...
07/31/2024 14:30:10

Barclays analyst Peter Lawson maintains Macrogenics (NASDAQ:MGNX) with a Overweight and lowers the price target from $9 to $8.

Core News & Articles
Market-Moving News for July 31st
07/31/2024 12:28:10

MHUA: 121% | Meihua International Announced That Its NT-2000 Surgical Path Analysis System Successfully Supported The World'...

pinterest-issues-weak-revenue-forecast-joins-groupon-o-i-glass-and-other-big-stocks-moving-lower-in-wednesdays-pre-market-session
Pinterest Issues Weak Revenue Forecast, Jo...
07/31/2024 12:27:51

guggenheim-downgrades-macrogenics-to-neutral
Guggenheim Downgrades Macrogenics to Neutral
07/31/2024 10:09:11

Guggenheim analyst Kelsey Goodwin downgrades Macrogenics (NASDAQ:MGNX) from Buy to Neutral.

b-riley-securities-downgrades-macrogenics-to-neutral-lowers-price-target-to-5
B. Riley Securities Downgrades Macrogenics...
07/31/2024 09:58:44

B. Riley Securities analyst Mayank Mamtani downgrades Macrogenics (NASDAQ:MGNX) from Buy to Neutral and lowers the price tar...

why-amd-shares-are-trading-higher-by-over-9-here-are-20-stocks-moving-premarket
Why AMD Shares Are Trading Higher By Over ...
07/31/2024 09:46:00

macrogenics-provides-vobramitamab-duocarmazine-update-abstract-of-clinical-data-accepted-for-poster-presentation-at-esmo-congress-2024-in-september-gives-tamarack-study-update-says-patient-safety-is-our-top-priority-and-having-reached-the-studys-primary-endpoint-we-decided-to-discontinue-additional-dosing-for-the-remaining-tamarack-participants-who-had-not-yet-completed-treatment
MacroGenics Provides Vobramitamab Duocarma...
07/30/2024 20:20:54

TAMARACK Study UpdateMacroGenics completed enrollment of the TAMARACK study in the fourth quarter of 2023, and plans to present...

Core News & Articles
MacroGenics Achieves $100M In Milestones R...
07/30/2024 20:19:14

MacroGenics, Inc. (NASDAQ:MGNX), a biopharmaceutical company focused on discovering, developing, manufacturing and commercializ...

expert-outlook-macrogenics-through-the-eyes-of-7-analysts
Expert Outlook: Macrogenics Through The Ey...
07/29/2024 16:00:51

barclays-maintains-overweight-on-macrogenics-lowers-price-target-to-9
Barclays Maintains Overweight on Macrogeni...
07/29/2024 15:30:29

Barclays analyst Peter Lawson maintains Macrogenics (NASDAQ:MGNX) with a Overweight and lowers the price target from $14 to $9.

dexcom-zynex-olin-and-other-big-stocks-moving-lower-in-fridays-pre-market-session
DexCom, Zynex, Olin And Other Big Stocks M...
07/26/2024 12:05:15

why-science-applications-international-shares-are-trading-lower-by-11-here-are-other-stocks-moving-in-mondays-mid-day-session
Why Science Applications International Sha...
06/03/2024 17:56:53

demystifying-macrogenics-insights-from-14-analyst-reviews
Demystifying Macrogenics: Insights From 14...
05/24/2024 18:00:53

btig-maintains-buy-on-macrogenics-lowers-price-target-to-9
BTIG Maintains Buy on Macrogenics, Lowers ...
05/24/2024 17:02:20

BTIG analyst Kaveri Pohlman maintains Macrogenics (NASDAQ:MGNX) with a Buy and lowers the price target from $24 to $9.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION